AzTrials
AzTrials

Post-stroke AphasiaNAILNCT04081207

Using Augmentative & Alternative Communication to Promote Language Recovery for People With Post-Stroke Aphasia

A study testing AAC for Language Recovery (AAC-LaRc) in people with Post-stroke Aphasia and Aphasia, run by University of Cincinnati at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The currently available interventions only partially restore language abilities in patients with post-stroke aphasia; preventing successful reintegration into society. This study will increase our knowledge of how we can use assistive technology interventions to help people with aphasia restore language function. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post-stroke Aphasia, Aphasia
What is being tested?
AAC for Language Recovery (AAC-LaRc)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
1 Sep 2018to Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • at least 18 years old
  • native speaker of american English
  • compatible for 3 Tesla MRI
  • Ischemic, left middle cerebral artery stroke
  • at least 12 months post stroke
  • pass hearing screening
Show all 12Show fewer
  • pass vision screening
  • diagnosis of aphasia on the Western Aphasia Bedside Screen
  • ability to produce 5-10 intelligible words
  • no more than a moderate apraxia of speech or dysarthria
  • minimal or no AAC/iPad experience
  • written consent by self or guardian

Who cannot join

  • fails to meet the above
  • Underlying degenerative or metabolic disorder or supervening medical illness
  • Severe depression or other psychiatric disorder
  • Report of pregnancy by women of childbearing age

Trial locations and contacts

1 site in 1 country.

Aimee Dietz, PhD contact

513-558-8551

aimee.dietz@uc.edu

Jennifer Vannest, PhD contact

513-558-8518

vannesjr@ucmail.uc.edu

United States1 site, 1 recruiting
  • University of Cincinnati

    Cincinnati, Ohio, 45267

    Aimee Dietz, PhD, 513-558-8551, aimee.dietz@uc.edu

    Jennifer Vannest, BS, 513-558-85418 ext. Dietz, aimee.dietz@uc.edu

    Recruiting

Other trials in United States

About this study

Official title: A Preliminary Study of the Neurobiology of AAC-Induced Language Recovery in Post-Stroke Aphasia

The currently available interventions only partially restore language abilities in patients with post-stroke aphasia; preventing successful reintegration into society. This study will increase our knowledge of how we can use assistive technology interventions to help people with aphasia restore language function. Further, this project will help us identify regions of the brain responsible for these changes.

Read the detailed description

In aphasia rehabilitation, usual care is focused on helping people recuperate as much of their pre-stroke language capacity as possible.Typically, usual care is a non-standardized therapy that is tailored to the specific needs of the person with aphasia.Once a person reaches a plateau in language recovery, AAC is implemented with a focus on circumventing, or compensating for the communication challenges associated with aphasia.

The ability of people with aphasia to (1) recover language function well-into the chronic phase of stroke recovery and (2) self-cue to promote word retrieval during anomic events offer the solution for how AAC could be employed as a dual-purpose tool to augment language recovery and compensate for deficits. This approach, however, this requires a shift in how AAC is implemented. With the goal of language recovery, treatment needs to focus on instructing people with aphasia how to use AAC as a mechanism for self-cueing, rather than as a tool to replace speaking. Based on our pilot data, we hypothesize that this novel method to AAC implementation will promote language recovery by coupling the canonical language and visual processing neural networks.

This work will also contribute to our ability to identify, a priori, who will respond to this particular AAC intervention and who will not, by combining neuroimaging with behavioral and clinical data. This has the potential to reduce the cost of healthcare for stroke recovery by implementing the most effective treatment possible. Importantly, when we identify non-responders, this will allow us to construct a profile and identify features of the AAC treatment that require adjustment to meet their unique needs.

Being tested
AAC for Language Recovery (AAC-LaRc)
Keywords
augmentative and alternative communication, aphasia, fMRI, DTI, neuroimaging
Medical subject headings
Aphasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AAC for Language Recovery (AAC-LaRc)Behavioural

    iPads will be programmed with a personalized communication application (app) and a structured 4-step intervention will be employed to instruct patients how to cue themselves during anomic events via pictures, text, or speak buttons.

Study groups in NCT04081207
Study groupRoleWhat they receive
AAC-LaRcExperimentalall participants receive the experimental treatment
Receives: Behavioral: AAC for Language Recovery (AAC-LaRc)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Western Aphasia Battery-Revised Aphasia Quotient

    a diagnostic tool used to determine aphasia type and severity

    Measured: 3 years

  2. Visual Regions of Interest Activation intensity

    A functional magnetic resonance imaging (fMRI) measure to indicate change in brain involvement during resting state and language tasks.

    Measured: 3 years

  3. Connectivity Indices

    Connectivity indices reflect the temporal correlation between canonical language and visual regions of interest during language and resting state fMRI tasks.

    Measured: 3 years

Secondary outcomes (8)
  1. Motor-Free Visual Perception Test-4

    The Motor-Free Visual Perception Test-4 assesses visual perceptual ability without requiring motor responses.

    Measured: 3 years

  2. Discourse Analyses

    We will calculate percentage of counted words, mazes, correct information units, t-units, during personal story retells with and without the AAC support.

    Measured: 3years

  3. Communication analyses

    We will calculate percentage of communication conveyed via pictures, text boxes, and speak button during personal story retells with and without the iPad AAC support.

    Measured: 3 years

  4. Stroke and Aphasia Quality of Life-39 (SAQOL-39)

    The SAQOL-39 is a valid and reliable measure of health related quality of life, post-stroke that uses an aphasia friendly 5 point Likert scale format.

    Measured: 3 years

  5. Communication Effectiveness Index (CETI)

    The CETI measures functional communication scenarios that caregivers rate the ability of the patient to complete tasks, as compared to before their stroke, via a 10 cm visual analogue scale.

    Measured: 3 years

  6. Fractional Anisotropy (FA)

    FA is a value of diffusion and reflects white matter density and myelination. We will examine the following tracts: (1) superior, (2) inferior fronto-occipital, (3) middle longitudinal, (4) inferior longitudinal fasciculus, (5) arcuate, and (6) uncinate

    Measured: 3 years

  7. Mean Diffusivity (MD)

    MD is used to map tracts and serves as a measure of health or disease in white matter. We will determine the MD for the following pathways: (1) superior, (2) inferior fronto-occipital, (3) middle longitudinal, (4) inferior longitudinal fasciculus, (5) arcuate, and (6) uncinate

    Measured: 3 years

  8. Language Lateralization Indices (LI)

    LI is a measure that reflects hemispheric dominance for language, while accounting for lesioned tissue.

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2019
  2. Study start1 Sep 2018
  3. Primary completionAug 2021 (estimated)
  4. Study completionDec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Participant cohorts: We will use a 2 (groups) X 4 (measurement time points) switching replications design\[18\] to examine the effects of AAC on aphasia severity and spoken language (AIM 1), elucidate the neurobiological mechanism of AAC-induced language recovery (AIM 2), and identify AAC treatment responder subgroups (Exploratory Aim). This design will allow Group 2 to serve as the control group; however, they will still receive AAC treatment; thus, allowing us to increase the total N who receives AAC treatment to 20 people.
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04081207
Sponsor's protocol ID
1R15DC017280-01
Acronym
NAIL
Status last verified
Sep 2019
First submitted
4 Sep 2019
Last updated
9 Sep 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Even though the final dataset will be stripped of identifiers prior to release for sharing, we believe that there remains the possibility of deductive disclosure of subjects based on their private health information and language profiles. Further, it is possible to reconstruct faces from MRI data and the patients are easily identified through the testing and treatment videos; thus, we will make the data and associated documentation available to users only under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed. Data will be shared at the time of publication, or shortly thereafter.

Publications

  • Dietz A, Vannest J, Maloney T, Altaye M, Holland S, Szaflarski JP. The feasibility of improving discourse in people with aphasia through AAC: Clinical and functional MRI correlates. Aphasiology. 2018;32(6):693-719. doi: 10.1080/02687038.2018.1447641. Epub 2018 Mar 9.

    PubMed 32999522

Questions about this trial

What is this clinical trial studying?

A study testing AAC for Language Recovery (AAC-LaRc) in people with Post-stroke Aphasia and Aphasia, run by University of Cincinnati at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Aimee Dietz, PhD (513-558-8551, aimee.dietz@uc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Western Aphasia Battery-Revised Aphasia Quotient (time frame: 3 years). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04081207, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in